Unraveling exhaustion in adaptive and conventional NK cells.
Immune exhaustion in T cells significantly impacts their ability to control malignancies and infections, and its discovery has led to revolutionary therapies for cancer in the form of checkpoint blockade. NK cells, like T cells, are lymphocytes that recognize virally infected and malignantly transformed cells. However, it remains unclear if NK cells are similarly susceptible to exhaustion. In this review, the aims are to summarize what is currently known and to identify key areas of variability that skew the scientific literature on NK cell exhaustion. A lack of consensus on the defining features of NK cell dysfunctional states such as senescence, suppression, and exhaustion has made a comparison between studies difficult. There are also significant differences in the biology of NK cell subsets with long-lived, adaptive NK cells sharing an epigenetic signature closer to memory CD8+  T cells than to conventional NK cells. Very different checkpoint receptor expression and effector functions have been shown in adaptive versus conventional NK cells chronically exposed to activating signals. Adaptive NK cells develop in individuals with cytomegalovirus (CMV) infection and well over half of the human population worldwide is CMV seropositive by adulthood. Despite this high prevalence, most studies do not account or control for this population. This may contribute to some of the variability reported in the literature on checkpoint receptor expression on NK cells. In this review, the protective role that exhaustion plays in T cells will also be discussed and the evidence for a similar phenomenon in NK cells will be examined.
['Merino|Aimee M|AM|0000-0003-4433-0127', 'Kim|Hansol|H|', 'Miller|Jeffrey S|JS|', 'Cichocki|Frank|F|']
D056704:Adaptive Immunity D018414:CD8-Positive T-Lymphocytes D016922:Cellular Senescence D002908:Chronic Disease D003587:Cytomegalovirus D003586:Cytomegalovirus Infections D006801:Humans D007156:Immunologic Memory D007694:Killer Cells, Natural
Exhaustion adaptive checkpoint receptor LAG-3 Natural Killer PD-1